Volume 5 Supplement 8

22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies

Open Access

Next-generation sequencing of the CHO cell transcriptome

  • Jennifer Becker1Email author,
  • Christina Timmermann1,
  • Tobias Jakobi2,
  • Oliver Rupp2,
  • Rafael Szczepanowski3,
  • Matthias Hackl4,
  • Alexander Goesmann2,
  • Andreas Tauch3,
  • Nicole Borth4,
  • Johannes Grillari4,
  • Alfred Pühler3,
  • Thomas Noll1 and
  • Karina Brinkrolf3
BMC Proceedings20115(Suppl 8):P6

DOI: 10.1186/1753-6561-5-S8-P6

Published: 22 November 2011

Since 1957 Chinese hamster ovary (CHO) cells are used for in vitro cultivation as they require assimilable low sustenance [1]. Today, CHO cell lines represent the most commonly used mammalian expression system for the production of therapeutic proteins and are considered as the mammalian equivalent of E. coli in research and biotechnology [2]. The production of biopharmaceuticals in CHO cells is superior to protein production in bacteria, because mammalian cell lines procure complex folding and post-translational modifications like glycosylation. However, contrary to the increasing importance in biotechnology and industry, comprehensive genome and transcriptome information of CHO cell lines is still rare.

In this study, the pyrosequencing technology from 454 Life Sciences and a novel assembly approach for cDNA sequences were used to achieve a major step forward towards unraveling the transcriptome of CHO cells.

CHO cDNA samples derived from different CHO cell lines and growth conditions were used for the generation of 1.84 mill. high quality sequencing reads with an average read length of 373 nt summing up to 603 Mb data. Assembly of the sequencing data resulted in 41,039 contiguous sequences. These contigs were grouped by the Newbler software into 36,383 isotigs and 28,039 isogroups.

Taxonomical classification and comparison to the Mus musculus transcriptome demonstrated the actual quality of the CHO cell line sequences.

Metabolic pathways of the central carbohydrate metabolism and biosynthesis routes of sugars used for protein N-glycosylation were reconstructed from the transcriptome data. All relevant genes representing major steps in the N-glycosylation pathway and the central metabolism of CHO cells were detected. Only fructose-1,6-bisphosphatase (3.1.3.11) and 6-phosphogluconolactonase (3.1.1.31) were not identified within the pentose phosphate pathway.

The newly sequenced CHO cell line transcriptome was the basis for the design of a customized CHO microarray. Contig sequences were used for the design of 94.580 probes. The designed probes cover 31,905 splice variants of CHO transcripts. With a Self-Self Hybridization experiment (Figure 1) the functionality of the probes was demonstrated. This experiment was performed with the same RNA as which was used for sequencing. Half of this RNA was labeled with Cy3, the other half with Cy5. For this study the dye intensity, the dye ratio and the adjusted p-value (student´s t-test, FDR controlled, α=0.05) of four microarray replicates were analyzed. It is expected, that the two labeled RNA samples bind equally to the probe, if a transcript is expressed (Figure 1: pink, dark blue, red, light blue). Only the probes for one transcript could be rejected, because of their dysfunctionality (Figure 1, green).
https://static-content.springer.com/image/art%3A10.1186%2F1753-6561-5-S8-P6/MediaObjects/12919_2011_Article_924_Fig1_HTML.jpg
Figure 1

Self-Self Hybridization experiment of the customized CHO microarray. The dye ratio (M-value) is plotted against the adjusted p-value (student´s t-test, FDR controlled, α=0.05). The dye ratio was calculated using the mean intensity values (A-value) of all probes belonging to one transcript from four microarray replicates. Different thresholds were used as evidence for quality: p > 0.05, M= - 1< M < 1 (pink); p ≤ 0.05, -1 < M < 1 (dark blue); p ≤ 0.05, M ≤ -1 || M ≥ 1, A < 6 (red); p ≤ 0.05, M ≤ -1 || M ≥ 1, A ≥ 6 (green); p > 0.05, M ≤ -1 || M ≥ 1 (light blue).

This CHO microarray is now available for further experiments and will support transcriptional analysis of CHO cells under process conditions for cell line and process optimization. It was used already used successfully for a gene expression study of CHO DP-12 cells cultivated under sodium butyrate treatment [3].

Declarations

Acknowledgements

JB, TJ, and JS acknowledge the receipt of a scholarship from the CLIB Graduate Cluster Industrial Biotechnology. CT is supported by BIO.NRW of the Cluster Biotechnology of North Rhine Westphalia. MH is supported by a BOKU DOC grant. NB and JG are supported by FWF Biotop, JG is supported by GENAU.

Authors’ Affiliations

(1)
Department of Cell Culture Technology, Center of Biotechnology (CeBiTec), Bielefeld University
(2)
Bioinformatics Resource Facility, Center of Biotechnology (CeBiTec), Bielefeld University
(3)
Department of Genome Research and Systems Biology, Center of Biotechnology (CeBiTec), Bielefeld University
(4)
Department of Biotechnology, University of Natural Resources and Applied Life Sciences Vienna

References

  1. Puck TT, Cieciura SJ, Robinson A: Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects. J Exp Med. 1958, 108: 945-956. 10.1084/jem.108.6.945.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Puck TT: Development of the Chinese Hamster Ovary (CHO) Cell. Molecular Cell Genetics. 1985, 1: 37-64.Google Scholar
  3. Klausing S, et al: Bioreactor cultivation of CHO DP-12 cells under sodium butyrate treatment and comparative transcriptome analysis with CHO cDNA microarrays

Copyright

© Becker et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement